ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml
Product details
Registration number: SIN17246P
Classification: Prescription Only
Active ingredients: Serplulimab
Strength: 100mg/10ml
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Route: INTRAVENOUS
Registrant: ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
ATC code: L01FF12
HSA approval date: 29 May 2025
Manufacturer(s): Shanghai Henlius Biopharmaceutical Co. Ltd.
Manufacturing country/countries: CHINA
What are the HSA registration number and classification for ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17246P
Classification: Prescription Only
What active ingredients and strength are recorded for ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Serplulimab
Strength: 100mg/10ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION, CONCENTRATE
Route: INTRAVENOUS
Who is the recorded registrant for ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml?
According to the HSA dataset updated 7 August 2026:
Registrant: ABBOTT LABORATORIES (SINGAPORE ) PRIVATE LIMITED
Which manufacturers and countries are listed for ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Shanghai Henlius Biopharmaceutical Co. Ltd.
Manufacturing country/countries: CHINA
Where can I look up ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17246P or the exact product name ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml. The general register link does not preselect this product.
What are the source dates for this ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ZERPIDIO (Serplulimab) Concentrate for Solution for Infusion 100mg/10ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17246P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)